Camelina lipid droplets as skin delivery system promotes wound repair by enhancing the absorption of hFGF2

Hongtao Gao,Fawei Wang,Xingli Hu,Yulin Li,Yuan Zhang,Kue Foka Idrice Carther,Bin Wang,Fei Min,Xue Wang,Hao Wu,Keheng Xu,Yonggang Zhou,Xin Liu,Xiaokun Li,Haiyan Li
DOI: https://doi.org/10.1016/j.ijpharm.2021.120327
IF: 6.51
2021-04-01
International Journal of Pharmaceutics
Abstract:<p>Human basic fibroblast growth factor (hFGF2) is widely recognized for accelerating skin wound healing in both animal models and randomized clinical trials. However, the low skin permeation and bioavailability of hFGF2 remain the most limiting factors in the pharmacological application. For the first time, Camelina Lipid Droplets (CLD) delivery system was displayed important virtue, by promoting the skin absorption of hFGF2, which is a key factor that accelerates the skin wound repair , and provide a new alternative for skin therapy. In this study, we used the CLD as a safer material to prepare the nanoparticles, which were characterized by size and morphology. Our data revealed that particle sizes of Camelina Lipid Droplets linked to hFGF2 (CLD-hFGF2) were around 133.5 nm; it also displayed that the complex of CLD-hFGF2 penetrates the skin barrier in deeper than an individual hFGF2. This suggests that once the hFGF2 is fixed onto the surface of CLD, it can cross the stratum corneum and play a therapeutic role into the dermis . Furthermore, we demonstrated that CLD-hFGF2 enhances fibroblast migration, and significantly improves skin regeneration for accelerating wound healing without any significant toxicity. This paper highlights the importance of CLD as an emerging delivery system; it is also providing a new and applicable therapeutic research direction through enhancing the skin permeation of hFGF2 to accelerate wound healing.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?